• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】37362

【品名】(2R,4S,5R)-4-(hydroxymethyl)-2-methyl-1,3-dioxan-5-ol

【CA登记号】

【 分 子 式 】C6H12O4

【 分 子 量 】148.15888

【元素组成】C 48.64% H 8.16% O 43.2%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(III)

Oxidative cleavage of 4,6-O-ethylidene glucose (I) with sodium periodate afforded 5-hydroxy-2-methyl-1,3-dioxan-4-carbaldehyde (II), which was reduced to alcohol (III) using sodium borohydride (1). Protection of the primary hydroxyl of (III) with tert-butyldimethylsilyl chloride, followed by Moffatt oxidation of the secondary hydroxyl group provided ketone (V). Subsequent Wittig reaction of (V) with ethyl (triphenylphosphoranylidene)acetate gave a mixture of E,Z unsaturated esters (VIa-b). Catalytic hydrogenation of the double bond of (VIa-b) produced the saturated ester (VIIa-b) as a diastereomeric mixture that was separated by column chromatography. Diisobutylaluminum hydride reduction of the desired ester furnished aldehyde (VIII), which was subjected to a Wittig reaction with the sodium salt of (4-carboxybutyl)triphenylphosphonium bromide (IX) yielding acid (X). Conversion of (X) to the methyl ester (XI) by methylation with iodomethane and K2CO3, followed by desilylation with Bu4NF afforded hydroxy ester (XII). Oxidation of the alcohol group of (XII) with Collins' reagent gave aldehyde (XIII). This was converted to the thiosemicarbazone (XV) upon condensation with phenyl thiosemicarbazide (XIV). Finally, the methyl ester group of (XV) was hydrolyzed, and the carboxylic acid was converted to the corresponding sodium salt.

1 Setoi, H.; Kuroda, A.; Tanaka, H.; Hirai, H.; Marusawa, H.; Hashimoto, M. (Fujisawa Pharmaceutical Co., Ltd.); Oxygen-containing heterocyclic cpd., processes for their preparation and pharmaceutical compsns. comprising them. EP 0346511 .
2 Kuroda, A.; setoi, H.; Motoyama, Y.; Sawada, A.; Seki, J.; Marusawa, H.; Tanaka, H.; Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A2 receptor antagonists. Bioorg Med Chem 1999, 7, 11, 2635.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
14182 ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane 1099-45-2 C22H21O2P 详情 详情
(VIa) 37365 ethyl 2-[(2R,4R)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-ylidene]acetate C16H30O5Si 详情 详情
(VIb) 37366 ethyl 2-[(2R,4R)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-ylidene]acetate C16H30O5Si 详情 详情
(VIIa) 37367 ethyl 2-[(2R,4R,5R)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-yl]acetate C16H32O5Si 详情 详情
(VIIb) 37368 ethyl 2-[(2R,4R,5S)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-yl]acetate C16H32O5Si 详情 详情
(I) 37360 (2R,4aR,7R,8R,8aS)-2-methylhexahydropyrano[3,2-d][1,3]dioxine-6,7,8-triol 13224-99-2 C8H14O6 详情 详情
(II) 37361 (2R,4R,5R)-5-hydroxy-2-methyl-1,3-dioxane-4-carbaldehyde C6H10O4 详情 详情
(III) 37362 (2R,4S,5R)-4-(hydroxymethyl)-2-methyl-1,3-dioxan-5-ol C6H12O4 详情 详情
(IV) 37363 (2R,4S,5R)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-ol C12H26O4Si 详情 详情
(V) 37364 (2R,4S)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-one C12H24O4Si 详情 详情
(VIII) 37369 2-[(2R,4R,5S)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-yl]acetaldehyde C14H28O4Si 详情 详情
(IX) 13616 (4-Carboxybutyl)triphenylphosphonium bromide 17814-85-6 C23H24BrO2P 详情 详情
(X) 37370 (Z)-7-[(2R,4R,5S)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-yl]-5-heptenoic acid C19H36O5Si 详情 详情
(XI) 37371 methyl (Z)-7-[(2R,4R,5S)-4-([[tert-butyl(dimethyl)silyl]oxy]methyl)-2-methyl-1,3-dioxan-5-yl]-5-heptenoate C20H38O5Si 详情 详情
(XII) 37372 methyl (Z)-7-[(2R,4R,5S)-4-(hydroxymethyl)-2-methyl-1,3-dioxan-5-yl]-5-heptenoate C14H24O5 详情 详情
(XIII) 37373 methyl (Z)-7-[(2R,4R,5S)-4-formyl-2-methyl-1,3-dioxan-5-yl]-5-heptenoate C14H22O5 详情 详情
(XIV) 37374 N-phenyl-1-hydrazinecarbothioamide 5351-69-9 C7H9N3S 详情 详情
(XV) 37375 methyl (Z)-7-((2R,4R,5S)-4-[[(E)-2-(anilinocarbothioyl)hydrazono]methyl]-2-methyl-1,3-dioxan-5-yl)-5-heptenoate C21H29N3O4S 详情 详情
Extended Information